Break it Down: Cash in the bag for Tryptamine Therapeutics
Stockhead TV
share
Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.
In this episode, host Fraser Palamara dissects the $6 million raising completed today by biotech company Tryptamine Therapeutics (ASX:TYP).
Money garnered from the placement, priced at 2c per share, will be used to accelerate the company’s studies in psilocybin and psilocin IV dosing to therapeutically treat patients.
Tune in to get the latest.
While Tryptamine Therapeutics is a Stockhead advertiser, it did not sponsor this content.
